Use In Geriatrics Use with Caution SEMALIX 3 TABLET should be used with caution in elderly patients aged 65 years and above
Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women, Obesity Research (2001) Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial, Obesity Research (2012) Long-term weight change after initiating second-generation antidepressants, Journal of Clinical Medicine (2016) The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials, Diabetology and Metabolic Syndrome (2024) A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II), Obesity (2013) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
2023;13:688 Hanna PE, Anders MW
Best support: Gradual loss, protein, resistance training, sunscreen, and barrier-friendly skincare
For a full scientific overview of PT-141, see our research reference page: PT-141 Overview Bulk orders automatically save 20% on any 10+ vials (BAC excluded) Important Notice: This product is sold strictly for laboratory research purposes only
Nutrition, exercise, and emotional well-being play a critical role in helping you thrive